DENVER, Sept. 18, 2017 -- Two-time Super Bowl Champion and All-Pro for the New York Giants Leonard Marshall has been nominated for the NFL Hall of Fame.
Videos accompanying this announcement are available at: http://www.globenewswire.com/NewsRoom/AttachmentNg/e969a109-845a-4abc-aa62-2fcc96f11a1e
http://www.globenewswire.com/NewsRoom/AttachmentNg/7b17c29c-2346-4e3a-86bf-e7efc228eb66
http://www.globenewswire.com/NewsRoom/AttachmentNg/8b88b463-0128-45d3-961d-485c8f882c38
Leonard’s storied NFL career is matched only by his post-football commitment to contribute positively to the lives of others, particularly children and other football players at all levels.
This nomination is also notable because Marshall is the first hemp cannabidiol advocate to be nominated to the NFL Hall of Fame.
As a founder of multiple nonprofits and a volunteer for hundreds more, Marshall has made philanthropy and advocacy his post-NFL career. As a C.T.E. survivor, one of Marshall’s passions is serving as a player advocate to ensure that former and current NFL players have access to hemp-based cannabidiol (CBD), a neuroprotective and anti-inflammatory. Diagnosed with C.T.E. in 2003, Marshall was one of the first living NFL players to receive this diagnosis.
“We’re incredibly proud of Leonard’s accomplishments – he is truly a warrior – as a player and a C.T.E. survivor. We’re delighted to see him nominated to the Football Hall of Fame, a fitting recognition of his football career,” said Gabriel Ettenson, Elixinol COO.
From this year’s nominees, 18 finalists will be presented to the Professional Hall of Fame’s Selection Committee, which will determine the final five in February 2018. The 48-member Selection Committee then votes yes or no on each of the final five. To be enshrined in the Hall of Fame, a finalist must receive at least 80% yes votes. [Editor’s note: See http://www.profootballhof.com/heroes-of-the-game/selection-process-faq/ for details on the selection process.]
About Elixinol:
Colorado-based Elixinol, founded by Paul Benhaim, hemp entrepreneur since 1991, is widely regarded as one of the world’s most influential CBD brands. With a proven track record of growing and manufacturing high-quality hemp, Elixinol also conducts rigorous laboratory testing and quality control. A global leader in hemp distribution, Elixinol distributes CBD products in 27 countries including the United States, Japan, Puerto Rico, Brazil and throughout Europe. More information is available at Elixinol.com.
Media Contact:
Chris Husong
Elixinol
+1 844-804-3504 ext 420
[email protected]


Uber and Baidu Partner to Test Robotaxis in the UK, Marking a New Milestone for Autonomous Ride-Hailing
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies
Moore Threads Unveils New GPUs, Fuels Optimism Around China’s AI Chip Ambitions
California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training
Hyundai Recalls Over 51,000 Vehicles in the U.S. Due to Fire Risk From Trailer Wiring Issue
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
South Korean Court Clears Korea Zinc’s $7.4 Billion U.S. Smelter Project, Shares Surge
Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift
ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants
GLP-1 Weight Loss Pills Set to Reshape Food and Fast-Food Industry in 2025
Italy Fines Apple €98.6 Million Over App Store Dominance 



